[Radioimmunological and immunological follow-up of toxic goiter remission following radiotherapy and thyroidectomy].
The paper is concerned with a multimodality approach to the assessment of clinical remission in 42 patients after radical therapy of toxic goiter. T4, T3, sigma TSH, delta TSH were determined in the thyrotropin releasing hormone stimulation test (TRH-test); some immunological indices (RFCc, RFCn, RFC1, a stimulation index [SI] LBTR, a migration index [MI] in the LMIT and serum immunoglobulins) were also investigated. The abnormal TRH-test was revealed in 2/3 of the patients (the hypo-TRH-test in 10 and the hyper-TRH-test in 11). A conclusion was made of the appropriateness of the multimodality approach to the assessment of toxic goiter remission after therapy.
D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D006111:Graves Disease / Q000175:diagnosis* / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D007159:Immunologic Tests; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011863:Radioimmunoassay; D013963:Thyroid Hormones / Q000097:blood; D013965:Thyroidectomy; D013973:Thyrotropin-Releasing Hormone; D013997:Time Factors
D007457:Iodine Radioisotopes; D013963:Thyroid Hormones; D013973:Thyrotropin-Releasing Hormone
Radioimmunologicheskiĭ i immunologicheskiĭ kontrol' remissii toksicheskogo zoba posle radioterapii i tireoidéktomii.